Anti-NSCLC activity in vitro of Hsp90N inhibitor KW-2478 and complex crystal structure determination of Hsp90N-KW-2478

Adams, 2010, PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta crystallographica, Section D, Biological crystallography, 66, 213, 10.1107/S0907444909052925 Akram, 2018, Therapeutic Uses of HSP90 Inhibitors in Non-Small Cell Lung Carcinoma (NSCLC), Curr. Drug Metab., 19, 335, 10.2174/1389200219666180307122441 Balandis, 2020, Synthesis and structure-affinity relationship of chlorinated pyrrolidinone-bearing benzenesulfonamides as human carbonic anhydrase inhibitors, Bioorg. Chem., 97, 10.1016/j.bioorg.2020.103658 Bernacchi, 2020, Analysis of the HIV-1 Genomic RNA Dimerization Initiation Site Binding to Aminoglycoside Antibiotics Using Isothermal Titration Calorimetry, Methods in molecular biology (Clifton N.J.), 2113, 237, 10.1007/978-1-0716-0278-2_16 Cao, 2017, Discovery of a novel small inhibitor RJ19 targeting to human Hsp90, Nuclear Science and Techniques (Nucl Sci Tech), 10, 70 Cavenagh, 2017, A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myeloma, Br. J. Cancer, 117, 1295, 10.1038/bjc.2017.302 Chatterjee, 2016, HSP90 inhibitors in lung cancer: promise still unfulfilled, Clinical advances in hematology & oncology : H&O, 14, 346 Feng Yu, Qisheng Wang, Minjun Li, Huan Zhou, Ke Liu, Kunhao Zhang, Zhijun Wang, Qin Xu, Chuanyan Xu, Qiangyan Pan, Jianhua He, 2019. Aquarium: an automatic data‐processing and experiment information management system for biological macromolecular crystallography beamlines. Journal of Applied Crystallography, 52(2). Gupta, 2019, Inhibiting protein-protein interactions of Hsp90 as a novel approach for targeting cancer, Eur. J. Med. Chem., 178, 48, 10.1016/j.ejmech.2019.05.073 He, 2014, Three-dimensional structure of a Streptomyces sviceus GNAT acetyltransferase with similarity to the C-terminal domain of the human GH84 O-GlcNAcase. Acta crystallographica, Section D, Biological crystallography, 70, 186, 10.1107/S1399004713029155 Hendriks, 2017, Heat shock protein antagonists in early stage clinical trials for NSCLC, Expert Opin. Invest. Drugs, 26, 541, 10.1080/13543784.2017.1302428 Ishii, 2012, Anti-tumor activity against multiple myeloma by combination of KW-2478, an Hsp90 inhibitor, with bortezomib, Blood Cancer J., 2, 10.1038/bcj.2012.13 Sławomir Kasperowicz, Ewa Marzec, Agnieszka M. Maciejewska, Damian Trzybiński, Maria Bretner, Krzysztof Woźniak, Jarosław Poznański, Kinga Mieczkowska, 2020. A competition between hydrophobic and electrostatic interactions in protein-ligand systems. Binding of heterogeneously halogenated benzotriazoles by the catalytic subunit of human protein kinase CK2. IUBMB life. Lelj-Garolla, 2015, Hsp27 Inhibition with OGX-427 Sensitizes Non-Small Cell Lung Cancer Cells to Erlotinib and Chemotherapy, Mol. Cancer Ther., 14, 1107, 10.1158/1535-7163.MCT-14-0866 Li, 2012, Structure insights into mechanisms of ATP hydrolysis and the activation of human heat-shock protein 90, Acta Biochim. Biophy. Sin., 44, 300, 10.1093/abbs/gms001 Li, 2017, LncRNA UCA1 Promotes Mitochondrial Function of Bladder Cancer via the MiR-195/ARL2 Signaling Pathway, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 43, 2548, 10.1159/000484507 Molina, 2013, Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay, Science (New York N.Y.), 341, 84, 10.1126/science.1233606 Molina, 2008, Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship, Mayo Clin. Proc., 83, 584, 10.1016/S0025-6196(11)60735-0 Nakashima, 2010, New molecular and biological mechanism of antitumor activities of KW-2478, a novel nonansamycin heat shock protein 90 inhibitor, in multiple myeloma cells, Clinical cancer research : an official journal of the American Association for Cancer Research, 16, 2792, 10.1158/1078-0432.CCR-09-3112 Olszewska, 2020, A novel trifluoromethyl 2-phosphonopyrrole analogue inhibits human cancer cell migration and growth by cell cycle arrest at G1 phase and apoptosis, Eur. J. Pharmacol., 871, 10.1016/j.ejphar.2020.172943 Prodromou, 2000, The ATPase cycle of Hsp90 drives a molecular 'clamp' via transient dimerization of the N-terminal domains, The EMBO journal, 19, 4383, 10.1093/emboj/19.16.4383 Siegel, 2020, Cancer statistics, 2020, CA Cancer J. Clin., 70, 7, 10.3322/caac.21590 Stebbins, 1997, Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent, Cell, 89, 239, 10.1016/S0092-8674(00)80203-2 Tabata, 2020, Inhibition of HSP90 overcomes melphalan resistance through downregulation of Src in multiple myeloma cells, Clinical and experimental medicine, 20, 63, 10.1007/s10238-019-00587-2 Taipale, 2010, HSP90 at the hub of protein homeostasis: emerging mechanistic insights, Nat. Rev. Mol. Cell Biol., 11, 515, 10.1038/nrm2918 Wang, 2018, Upgrade of macromolecular crystallography beamline BL17U1 at SSRF, Nuclear Science and Techniques (Nucl Sci Tech), 29, 3 Whitesell, 2005, HSP90 and the chaperoning of cancer, Nat. Rev. Cancer, 5, 761, 10.1038/nrc1716 Winn, 2011, Overview of the CCP4 suite and current developments. Acta crystallographica, Section D, Biological crystallography, 67, 235, 10.1107/S0907444910045749 Xue, 2016, Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway, Cancer Sci., 107, 18, 10.1111/cas.12844 Ye, 2017, Effect of norcantharidin on the proliferation, apoptosis, and cell cycle of human mesangial cells, Ren. Fail., 39, 458, 10.1080/0886022X.2017.1308257 Yong, 2016, Phase I study of KW-2478, a novel Hsp90 inhibitor, in patients with B-cell malignancies, Br. J. Cancer, 114, 7, 10.1038/bjc.2015.422